1. Home
  2. PRSU vs ANNX Comparison

PRSU vs ANNX Comparison

Compare PRSU & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pursuit Attractions and Hospitality Inc.

PRSU

Pursuit Attractions and Hospitality Inc.

HOLD

Current Price

$35.62

Market Cap

946.6M

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.64

Market Cap

918.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSU
ANNX
Founded
1926
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
946.6M
918.2M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PRSU
ANNX
Price
$35.62
$5.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$31.67
$16.50
AVG Volume (30 Days)
267.5K
2.3M
Earning Date
02-25-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
902.95
N/A
EPS
10.75
N/A
Revenue
$441,143,000.00
N/A
Revenue This Year
$26.24
N/A
Revenue Next Year
$6.25
N/A
P/E Ratio
$3.51
N/A
Revenue Growth
4.63
N/A
52 Week Low
$26.66
$1.29
52 Week High
$41.72
$7.18

Technical Indicators

Market Signals
Indicator
PRSU
ANNX
Relative Strength Index (RSI) 56.99 45.15
Support Level $34.05 $6.10
Resistance Level $35.90 $6.59
Average True Range (ATR) 1.13 0.43
MACD 0.13 -0.14
Stochastic Oscillator 81.50 10.57

Price Performance

Historical Comparison
PRSU
ANNX

About PRSU Pursuit Attractions and Hospitality Inc.

Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: